Fig. 5From: Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic miceEffect of AS-IV and NLRP3 inhibitor on GDM symptoms in mice model. Serum concentration of glucose (a) and insulin (b) in pregnant GDM mice treated with AS-IV or glyburide (a specific inhibitor of NLRP3) were measured on GD14. c Protein levels of IL-6 and TNF-α in the pancreas of pregnant GDM mice treated with AS-IV or glyburide. β-actin was set as control protein. Data was presented as mean ± SD. n = 8. **p < 0.01, ns, no significant differenceBack to article page